Germany-based drug conglomerate Bayer AG has received approval from the US Federal Trade Commission to acquire contraceptive company Conceptus. Bayer has made an offer of $1.1 billion in a move the company says will help expand its birth control businesses. An announcement to buy the California-based company was made last month. While Bayer already markets various birth control pills, Conceptus specializes in an irreversible birth control method. The parties expect to complete the deal by the middle of the year.
Featured News
DOJ Clears Paramount’s $110 Billion Warner Bros. Discovery Acquisition
Jun 12, 2026 by
CPI
States Move Ahead with AI Safeguards for Minors as Federal Action Remains Uncertain
Jun 12, 2026 by
CPI
Dana, Eaton Strike Auto Parts Deal Worth More Than $10 Billion
Jun 11, 2026 by
CPI
CFTC Proposes New Rules For What’s Allowed on Prediction Markets
Jun 11, 2026 by
CPI
Connecticut vs. California’s Data Broker Laws: New Compliance Challenges
Jun 11, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – (Geo)Political Antitrust
May 28, 2026 by
CPI
Competition Policy in Turbulent Geopolitical Times
May 28, 2026 by
Christophe Carugati & Annabelle Gawer
The New Political Determinants of U.S. Antitrust Policy
May 28, 2026 by
Aziz Z. Huq
The Geopolitical Rewiring of Antitrust
May 28, 2026 by
Hayane C. Dahmen
Three Strikes Against Political Antitrust
May 28, 2026 by
Nolan McCarty & Sepehr Shahshahani